Needle exchange is not enough: Lessons from the Vancouver injecting drug use study

AIDS

Volumn 11, Issue 8, 1997, Pages

  Strathdee, Steffanie A ^a,b,d   Patrick, David M ^b,c   Currie, Sue L ^a   Cornelisse, Peter G A ^a   Rekart, Michael L ^b,c   Montaner, Julio S G ^a,b   Schechter, Martin T ^a,b   O'Shaughnessy, Michael V ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MINISTRY OF HEALTH   (Canada)

^d Brit Columbia Ctr Excell HIV/AIDS   (Canada)

Author keywords

Harm seduction; HIV 1; Incidence; Injecting drug users; Needle exchange; Needle sharing; Prevalence

Indexed keywords

COCAINE;

ARTICLE; CANADA; CAUCASIAN; CLINICAL TRIAL; COHORT ANALYSIS; DEMOGRAPHY; EDUCATION; ETHNIC GROUP; FEMALE; HEALTH BEHAVIOR; HEALTH PROGRAM; HEPATITIS C; HEPATITIS C VIRUS; HOUSING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INSTRUMENT STERILIZATION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEEDLE; NONHUMAN; PRIORITY JOURNAL; PROSTITUTION; QUESTIONNAIRE; REGRESSION ANALYSIS; SEROCONVERSION; SEROLOGY; SYRINGE;

ADOLESCENT; ADULT; CANADA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEEDLE-EXCHANGE PROGRAMS; PROSPECTIVE STUDIES; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0030978971     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199708000-00001     Document Type: Article

References (31)

1. Bardsley I, Turvey J, Blatherwick J: Vancouver's needle exchange program. Can J Public Health 1990, 81:39-45.
2. Rekart ML, McCarthy M, Farrow C: AIDS street nurses. V International Conference on AIDS. Montreal, June 1989 [abstract MAP111].
3. Cook DA, Patrick DM, Rekart ML, et al.: Enhanced surveillance for HIV infection in British Columbia, Canada. XI International Conference on AIDS. Vancouver, July 1996 [abstract MoC333].
4. Strathdee SA, Schechter MT, Hogg RS, O'Shaughnessy MV: Trends in the epidemiology of HIV/AIDS in British Columbia. Br Columbia Med J 1994, 36:98-114.
5. Lurie P, Reingold A, Bowser B, et al.: The Public Health Impact of Needle Exchange Programs in the United States and Abroad: Summary, Conclusions and Recommendations. Berkeley/San Francisco: School of Public Health, University of California, Berkeley/Institute for Health Policy Studies, University of California, San Francisco; October 1993.
6. Patrick DM, Strathdee SA, Archibald CP, et al.: Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. Int J STD AIDS 1997 (in press).
7. Strathdee SA, Patrick DM, Archibald CP, et al.: Social determinants predict needle sharing behaviour among injection drug users in Vancouver, Canada. Addiction 1997 (in press)
8. Mirowsky J, Ross CE: Age and depression. J Health Soc Behav 1992, 33:187-205.
9. van Ameijden EJC, van den Hoek AAR, Coutinho RA: Injecting risk behaviors among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs. Am J Public Health 1994, 84:275-281.
10. Bruneau J, Lamothe F, Franco E, et al.: High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol 1997 (in press).
11. Nelson KE, Vlahov D, Solomon L, Cohn S, Munoz A: Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, MD. Arch Intern Med 1995, 155:1305-1311.
12. Des Jarlais DC, Marmor M, et al.: HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996, 348:987-991.
13. Hagan H, Des Jarlais DC, Friedman SR, Purchase D, Alter MJ: Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma Syringe Exchange Program. Am J Public Health 1995, 85:1531-1537.
14. van Ameijden EJC, Watters JK, van den Hoek JAR, Coutinho RA: Interventions among injecting drug users: do they work? AIDS 1995, 9 (suppl A):S75-S84.
15. Kaplan E, Heimer R: HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data. J Acquir Immune Defic Syndr 1994, 7:182-189.
16. van den Hoek JAR, van Haastrecht HJA, Coutinho RA: Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. Am J Public Health 1989, 79:1355-1357.
17. Hunter GM, Donoghoe MC, Stimson GV, Rhodes T, Chalmers CP: Changes in the injecting risk behaviour of injecting drug users in London, 1990-1993. AIDS 1995, 9:493-501.
18. Gostin LO, Lazzarini, Z, Jones TS, Flaherty K: Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. JAMA 1997, 277:53-62.
19. Friedman SR, Jose B, Deren S, Des Jarlais DC, Neaigus A: Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. Am J Epidemiol 1995, 142:864-875.
20. Vlahov D, Munoz A, Anthony JC, Cohn S, Celentano DD, Nelson KE: Association of drug injection patterns with antibody to human immunodeficiency virus type 1, among intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1990, 132:847-856.
21. Lamothe F, Bruneau J, Coates R, et al.: Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study. Can Med Assoc J 1993, 149:945-951.
22. Anthony JC, Vlahov D, Nelson KE, Cohn S, Astemborski J, Solomon L: New evidence on intravenous cocaine use and the risk of infection with human immunodefiency virus type 1. Am J Epidemiol 1991, 134:1175-1189.
23. Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR: Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989, 261:561-565.
24. Koester SK: Copping, running, and paraphenalia laws: contextual variables and needle risk behavior among injection drug users in Denver. Hum Organ 1994, 53:287-295.
25. Latkin C, Mandell W, Vlahov D, Oziemkowska M, Celentano D: People and places: behavioral settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr 1996, 13:273-280.
26. Neaigus A, Friedman SR, Jose B, et al.: High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr 1996, 11:499-509.
27. Hartgers C, Van Ameijden EJ, van den Hoek JA, Coutinho RA: Needle sharing and participating in the Amsterdam syringe exchange programme among HIV-seronegative injecting drug users. Public Health Rep 1992, 107:675-681.
28. Archibald CP, Ofner M, Patrick DM, et al.: Needle exchange program attracts high-risk injection drug users. XI International Conference on AIDS. Vancouver, July 1996 [abstract TuC320].
29. van Ameijden EJC, van den Hoek JAR, van Haastrecht HJA, Coutinho RA: The harm reduction approach and risk factors for human immunodeficiency virus seroconversion in injecting drug users, Amsterdam. Am J Epidemiol 1992, 139:1153-1163.
30. Frischer M, Haw S, Bloor M, et al.: Modeling the behavior and attributes of injecting drug users: a new approach to identifying HIV risk practices. Int J Addict 1993, 28:129-152.
31. Vlahov D, Junge B, Beilenson P, Brookmeyer RS, Cohn S, Armenian H: Evaluation of the Baltimore Needle Exchange Program: preliminary results. XI International Conference on AIDS. Vancouver, July 1996 [abstract MoD361].